Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
DoorDash’s 33.7% decline in Q1 compares to a 29.0% drop in Novo Nordisk shares – the Fund’s next most notable laggard. From a contribution...
— Alex Gunz
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Novo Nordisk A/S
More institutional theses from The Heptagon Future Trends Fund
As a dominant player in US and global LNG, Cheniere Energy offers highly predictable revenue with over 95% of its sales contracted through the mid-2030s on 20-year take-or-pay agreements. Historical revenue growth...
Galderma operates as a leading pure-play dermatology giant at the intersection of beauty and healthcare, consistently outgrowing its broader market. Guided by targets...
Equinix has built an unparalleled global footprint of data centers through substantial capital investment, addressing a rapidly growing 250 billion dollar market. With 95% recurring...